October 7, 2010 | Pacific Bioscience CEO Hugh Martin believes in full disclosure. When diagnosed with cancer, he told the entire staff of his company the full details. Almost exactly a year after his diagnosis, Martin is still leading the company that filed to go public with a $200 million public offering in August. Fortune